Other News

InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health

TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system has received a positive opinion from […]

Hyloris Acquires Breakthrough, Patented Technology to Develop and Market Aspirin IV in the U.S. in Acute Coronary Syndrome

Potential to revolutionise the current treatment paradigm and become the cornerstone therapy for patients with suspected acute coronary syndrome Enables accelerated development of HY-073 (IV acetylsalicylic acid), bringing the anticipated FDA submission date forward to end 2023 Initially targeting a total addressable patient population of ~2 million in the U.S. […]

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

Company’s signal processing technology for arrhythmia care to be featured during the event co-hosted by the University of Pennsylvania and The Mount Sinai Hospital Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing […]

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies

Technology Anticipated to Impact Cardiac Biologic Therapies, Transseptal Cardiac Procedures, and Other Interventional Catheter Based Therapies SAN CARLOS, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of U.S. Patent […]

AliveCor Launches AliveCor Labs

New National Cardiac Monitoring IDTF Will Offer All Technology Options Including KardiaMobile 6L, The World’s Only Pocket Sized Six-Lead Monitor MOUNTAIN VIEW, Calif., Oct. 12, 2021 /PRNewswire/ — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of AliveCor Labs, further establishing the company’s footprint in enterprise class clinical workflows. […]

Withings Announces the FDA Clearance of ScanWatch — Its Most Medically Advanced Hybrid Smartwatch

ScanWatch becomes the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist ISSY-LES-MOULINEAUX, France, Oct. 12, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, is pleased to announce ScanWatch, its globally acclaimed and most medically advanced wearable, […]

Q’Apel Medical, Inc. Awarded U.S. Patent for Its Highly Innovative SelectFlex™ Technology

FREMONT, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce today that the United States Patent & Trademark Office has granted the company U.S. Patent No. 11,123,522 covering important […]

CARMAT Announces the Publication of an Article on the Aeson®’s Autoregulation System in the ASAIO Journal

Results from 10 patients enrolled in the PIVOTAL study show that autoregulation enables an appropriate and immediate adaptation of cardiac output to patients’ needs CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic […]